medconn-History

1992

Medconn founded

2008

Developing 1st LPLC HbA1c Analyzer

2012

1st self-developed HbA1c (HPLC) analyzer launched in China

2016

MQ-6000 HPLC HaA1c Analyzer launched

CLIA (ALP+AMPPD) launched

2022

MQ-8000 HPLC HbA1c Analyzer launched

Allergy Analyzer launched

2023

Development of thalassemia screening (HbF/HbA2)

MQ-3000 HPLC HbA1c Analyzer launched

2024

Hematology solution launched

Introducing CLIA to Europe

2025

HbA1c (HPLC) approved by US FDA

Autoline MH-9000 launched

More products launched (Hemostasis, Mono test CLIA)

Future

Driven by Innovation, Committed to Reliability